NYSE - Delayed Quote • USD
Lazard, Inc. (LAZ)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 6:01 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 0.51 | 0.57 | 3.02 | 4.21 |
| Low Estimate | 0.21 | 0.35 | 2.7 | 3.8 |
| High Estimate | 0.82 | 0.82 | 3.53 | 4.82 |
| Year Ago EPS | -0.26 | 0.24 | 0.77 | 3.02 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 6 | 6 |
| Avg. Estimate | 668.12M | 659.03M | 2.89B | 3.17B |
| Low Estimate | 608.7M | 646.4M | 2.76B | 3.03B |
| High Estimate | 708.63M | 676.78M | 3.16B | 3.43B |
| Year Ago Sales | 527.02M | 620.03M | 2.44B | 2.89B |
| Sales Growth (year/est) | 26.80% | 6.30% | 18.40% | 9.60% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.26 | 0.1 | 0.16 | 0.41 |
| EPS Actual | -0.26 | 0.24 | 0.1 | 0.66 |
| Difference | -0.52 | 0.14 | -0.06 | 0.25 |
| Surprise % | -200.00% | 140.00% | -37.50% | 61.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.51 | 0.57 | 3.02 | 4.21 |
| 7 Days Ago | 0.51 | 0.57 | 3.02 | 4.21 |
| 30 Days Ago | 0.45 | 0.63 | 3.1 | 4.19 |
| 60 Days Ago | 0.46 | 0.64 | 3.11 | 4.2 |
| 90 Days Ago | 0.41 | 0.63 | 3.07 | 3.99 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | 4 | 1 | 2 | 2 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | LAZ | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 296.20% | -- | -- | 0.40% |
| Next Qtr. | 137.50% | -- | -- | 9.90% |
| Current Year | 292.20% | -- | -- | 4.30% |
| Next Year | 39.40% | -- | -- | 13.40% |
| Next 5 Years (per annum) | 7.30% | -- | -- | 11.09% |
| Past 5 Years (per annum) | -13.02% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight to Overweight | 4/11/2024 |
| Maintains | UBS: Neutral to Neutral | 3/26/2024 |
| Maintains | UBS: Neutral to Neutral | 2/5/2024 |
| Maintains | UBS: Neutral to Neutral | 1/9/2024 |
| Upgrade | Wolfe Research: Peer Perform to Outperform | 1/3/2024 |
Related Tickers
MC Moelis & Company
54.60
+2.59%
EVR Evercore Inc.
196.10
+2.09%
PJT PJT Partners Inc.
95.85
+0.47%
JEF Jefferies Financial Group Inc.
44.59
+2.44%
HLI Houlihan Lokey, Inc.
129.72
+1.37%
PWP Perella Weinberg Partners
15.97
+0.31%
SF Stifel Financial Corp.
77.88
+0.82%
PIPR Piper Sandler Companies
195.60
+2.16%
RJF Raymond James Financial, Inc.
127.14
+1.32%
NMR Nomura Holdings, Inc.
5.89
+0.17%